The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016.
作者信息
Rizzo Roberta, Fainardi Enrico, Rouas-Freiss Nathalie, Morandi Fabio
机构信息
Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Ferrara, Italy.
Neuroradiology Unit, Department of Diagnostic Imaging, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
出版信息
J Immunol Res. 2017;2017:2309574. doi: 10.1155/2017/2309574. Epub 2017 Jan 4.
Abstract
摘要
相似文献
1
The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016.
J Immunol Res. 2017;2017:2309574. doi: 10.1155/2017/2309574. Epub 2017 Jan 4.
2
HLA-G and MIC expression in tumors and their role in anti-tumor immunity.
Trends Immunol. 2003 Feb;24(2):82-7. doi: 10.1016/s1471-4906(02)00039-x.
3
HLA-G: on the track of immunological functions.
Eur J Immunogenet. 1997 Oct;24(5):397-408. doi: 10.1046/j.1365-2370.1997.d01-109.x.
4
Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
Hum Immunol. 2007 Apr;68(4):272-6. doi: 10.1016/j.humimm.2007.01.010. Epub 2007 Feb 20.
5
Non-classical HLA-G antigen and its role in the cancer progression.
Cancer Invest. 2006 Mar;24(2):178-86. doi: 10.1080/07357900500524579.
6
HLA-G and cancer.
Semin Cancer Biol. 2007 Dec;17(6):411-2. doi: 10.1016/j.semcancer.2007.06.014. Epub 2007 Jul 10.
7
Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules.
J Leukoc Biol. 2004 Dec;76(6):1125-33. doi: 10.1189/jlb.0104015. Epub 2004 Aug 26.
8
The role of HLA-G in immunity and hematopoiesis.
Cell Mol Life Sci. 2011 Feb;68(3):353-68. doi: 10.1007/s00018-010-0579-0. Epub 2010 Nov 30.
9
HLA-G expression in malignant melanoma.
Semin Cancer Biol. 2007 Dec;17(6):422-9. doi: 10.1016/j.semcancer.2007.06.010. Epub 2007 Jun 28.
10
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Semin Cancer Biol. 2007 Dec;17(6):459-68. doi: 10.1016/j.semcancer.2007.07.005. Epub 2007 Jul 31.
引用本文的文献
1
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer.
Cancers (Basel). 2024 Dec 22;16(24):4266. doi: 10.3390/cancers16244266.
2
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004863.
3
What Inhibits Natural Killers' Performance in Tumour.
Int J Mol Sci. 2022 Jun 24;23(13):7030. doi: 10.3390/ijms23137030.
4
Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion.
Viruses. 2021 Sep 17;13(9):1855. doi: 10.3390/v13091855.
5
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Front Immunol. 2021 Mar 9;12:636568. doi: 10.3389/fimmu.2021.636568. eCollection 2021.
6
HHV-6A Infection of Endometrial Epithelial Cells Induces Increased Endometrial NK Cell-Mediated Cytotoxicity.
Front Microbiol. 2017 Dec 15;8:2525. doi: 10.3389/fmicb.2017.02525. eCollection 2017.
Zotero 插件